Reisuke Yoshizawa
Assistant professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
About
Reisuke Yoshizawa is an Assistant Professor at Iwate Medical University in Japan. His research focuses on advanced cardiovascular interventions, including catheter ablation techniques and outcomes related to acute myocardial infarction. Recent publications highlight his work on the impact of natural disasters on cardiovascular syndromes and the effectiveness of various cardiac devices.
Articles (10)
Year:
2026
Year:
2025
Year:
2025
Common trunk of the inferior pulmonary veins (CIPV) is the rarest anatomical variant of the pulmonary vein, posing a challenge to catheter ablation for atrial fibrillation (AF). We show that cryoballoon ablation is safe and effective, and may be a first-line therapy option for AF in patients with CIPV.
Year:
2024
Year:
2023
Background It is established that pulmonary vein isolation using the POLARx™ (Boston Scientific, Marlborough, MA, USA) cryoballoon is a rapid, safe, and effective approach. The new POLARx™ FIT (Boston Scientific), which is expandable from 28 to 31 mm in diameter, is currently available. However, there is limited evidence available regarding the treatment of atrial fibrillation in this setting. In this article, we report a case series of cryoballoon ablation in patients with atrial fibrillation using POLARx™ FIT. Case summary This case series describes a comparison of obstruction in three patients with pulmonary veins of different shapes and diameters undergoing cryoballoon ablation and pulmonary vein isolation with a 31 mm diameter balloon. Discussion Cryoballoon ablation using the 31 mm mode of POLARx™ FIT has the potential to provide safe and stable pulmonary vein isolation with good occlusion for a variety of pulmonary vein geometries. In this case series, the 31 mm mode of the POLARx™ FIT resulted in better pulmonary vein occlusion than the 28 mm mode in patients with large left atria and large pulmonary veins, including the left common pulmonary vein. This approach may be considered a first-line therapy option of cryoballoon ablation in patients with atrial fibrillation.
Year:
2023
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Collaborators (1)
Shingen Owada
Iwate Medical University
Make your next move.
Prepare your application
Review drafts before you send them.